Global Pediatrics Partnering 2010-2016: Deal trends, players and financials

Published: July 2016
No. of Pages: 500
    ReportsandReports

Summary

Global Pediatrics Partnering 2010-2016: Deal trends, players and financials provides comprehensive understanding and unprecedented access t- the pediatrics partnering deals and agreements entered int- by the worlds leading healthcare companies

Global Pediatrics Partnering 2010 t- 2016 provides the full collection of Pediatrics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Pediatrics partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Pediatrics partnering agreement structure
Pediatrics partnering contract documents
Top Pediatrics deals by value
Most active Pediatrics dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right t- license a licensor’s product or technology. More often these days these deals tend t- be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Pediatrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Pediatrics deals.

The report presents financial deal terms values for Pediatrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers t- analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Pediatrics dealmaking trends.

Chapter 1 provides an introduction t- the report.

Chapter 2 provides an overview of the trends in Pediatrics dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Pediatrics deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Pediatrics dealmakers, together with a full listing of deals t- which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access t- the contract.

Chapter 5 provides comprehensive access t- Pediatrics deals since 2010 where a deal contract is available, providing the user with direct access t- contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink t- an online version of the deal record contract document, providing easy access t- each contract document on demand.

Chapter 6 provides a comprehensive directory of all Pediatrics partnering deals by specific Pediatrics target announced since 2010. The chapter is organized by specific Pediatrics therapeutic target. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Pediatrics partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.

The report als- includes numerous tables and figures that illustrate the trends and activities in Pediatrics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs t- know about partnering in the research, development and commercialization of Pediatrics technologies and products.

Report scope

Global Pediatrics Partnering 2010 t- 2016 is intended t- provide the reader with an in-depth understanding and access t- Pediatrics trends and structure of deals entered int- by leading companies worldwide.

Global Pediatrics Partnering 2010 t- 2016 includes:

Trends in Pediatrics dealmaking in the biopharma industry since 2010
Analysis of Pediatrics deal structure
Access t- headline, upfront, milestone and royalty data
Access t- hundreds of Pediatrics deal contract documents
Comprehensive access t- over 3500 Pediatrics deal records
The leading Pediatrics deals by value since 2010
Most active Pediatrics dealmakers since 2010

In Global Pediatrics Partnering 2010 t- 2016, available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.

The Global Pediatrics Partnering 2010-2016 report provides comprehensive access t- available deals and contract documents for over 200 pediatrics deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement t- the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Wh- is responsible for commercialization?
Wh- is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes t- be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear t- differ from partner t- partner or deal type t- deal type?
Which jurisdiction does the company insist upon for agreement law?
Global Pediatrics Partnering 2010 t- 2016 provides the reader with the following key benefits:

In-depth understanding of Pediatrics deal trends since 2010
Access Pediatrics deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between Pediatrics partner companies
Comprehensive access t- over 750 links t- actual Pediatrics deals entered int- by the world’s biopharma companies
Indepth review of Pediatrics deals entered int- by the top 25 most active dealmakers
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner Pediatrics opportunities
Uncover companies actively partnering Pediatrics opportunities

Published By: Current Partnering
Product Code: Current Partnering459


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • Global Human Coagulation Factor VIII Market Professional Survey Report 2017

    Notes: Production, means the output of Human Coagulation Factor VIII Revenue, means the sales value of Human Coagulation Factor VIII This report studies Human Coagulation Factor VIII in Global market, especially in North America, China, Europe, ...

  • Global Human Albumin Market Professional Survey Report 2017

    Notes: Production, means the output of Human Albumin Revenue, means the sales value of Human Albumin This report studies Human Albumin in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production...

  • Global Vegetarian Softgel Capsules Sales Market Report 2017

    Notes: Sales, means the sales volume of Vegetarian Softgel Capsules Revenue, means the sales value of Vegetarian Softgel Capsules This report studies sales (consumption) of Vegetarian Softgel Capsules in Global market, especially in United State...

  • Global Vegetable Capsules Sales Market Report 2017

    Notes: Sales, means the sales volume of Vegetable Capsules Revenue, means the sales value of Vegetable Capsules This report studies sales (consumption) of Vegetable Capsules in Global market, especially in United States, China, Europe and Japan,...

  • Global Specific Cancer Immunotherapy Drugs Sales Market Report 2017

    Notes: Sales, means the sales volume of Specific Cancer Immunotherapy Drugs Revenue, means the sales value of Specific Cancer Immunotherapy Drugs This report studies sales (consumption) of Specific Cancer Immunotherapy Drugs in Global market, es...

  • Global Paediatric Vaccine Market Research Report 2017

    Notes: Production, means the output of Paediatric Vaccine Revenue, means the sales value of Paediatric Vaccine This report studies Paediatric Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, ...

  • Global Veterinary Pharmaceuticals Market Research Report 2017

    Notes: Production, means the output of Veterinary Pharmaceuticals Revenue, means the sales value of Veterinary Pharmaceuticals This report studies Veterinary Pharmaceuticals in Global market, especially in North America, Europe, China, Japan, So...

  • Global Recombinant Non-glycosylated Protein Market Research Report 2017

    Notes: Production, means the output of Recombinant Non-glycosylated Protein Revenue, means the sales value of Recombinant Non-glycosylated Protein This report studies Recombinant Non-glycosylated Protein in Global market, especially in North Ame...

  • Global Recombinant Glycosylated Protein Market Research Report 2017

    Notes: Production, means the output of Recombinant Glycosylated Protein Revenue, means the sales value of Recombinant Glycosylated Protein This report studies Recombinant Glycosylated Protein in Global market, especially in North America, Europe...

  • Global Lixisenatide Market Research Report 2017

    Notes: Production, means the output of Lixisenatide Revenue, means the sales value of Lixisenatide This report studies Lixisenatide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top man...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: